Resources & Articles

The global health economics and outcomes research (HEOR) market continues to grow year over year and is estimated to reach 2.46 billion by 2026. Read on for a breakdown of the top 5 trends driving this exciting industry growth.

Whether or not you had the opportunity to attend the three action-packed days of ISPOR this year, we’ve got you covered with a summary of 4 major themes that emerged.

With increasing applications of real-world data (RWD) upstream in the drug development lifecycle, it’s critical to recognize that there is no one-size-fits-all approach. So how can one incorporate different types of data from patients into clinical trials? Through conversation with a panel of experts from the biopharma industry and health technology companies, we will discuss scenarios when patient-mediated, tokenized and/or site-based approaches are warranted. Gaelan Ritter, Sneha Kishnani, and Andrew Larsen share their unique perspectives on the importance of a tailored yet flexible strategy and the potential value this can unlock for researchers and patients alike.Watch the recorded webinar or read the transcript below to explore design considerations for incorporating different types of real-world data into clinical trials.

PicnicHealth is excited to announce that we are expanding our long-term partnership with Roche and Genentech to better understand brain health and accelerate neurological disease research using real-world data.

This year, the FDA shed light on important, cross-cutting considerations for patient-level, real-world data to serve as an external control arm. Our new blog post highlights what you need to know - and the data you need to have - to conduct an externally controlled trial.

CureDuchenne and PicnicHealth Announce Real-World Evidence-Focused Partnership to Incorporate Participant Medical Records into CureDuchenne Link

The studies presented at the HTRS Scientific Symposium showcase some of the many ways PicnicHealth is partnering with leading researchers to deliver robust real-world evidence and improving patient care across different therapeutic areas, including rare diseases, hematology, immunology, neurology, and oncology

PicnicHealth | Does a recent FDA approval signal changes for the wider industry when it comes to RWE?FDA approvals supported by Real-World Evidence (RWE) are rising. Life science companies would be remiss not to consider including evidence on the natural history of disease, unmet medical need, and/or patient-reported outcomes in their regulatory strategies. PicnicHealth has extensive experience helping life science companies execute strategies to leverage Real-World Data (RWD) and incorporate RWE into their research and business planning. Uncovering experiences and outcomes from real patients is at the heart of it all. Contact us to discuss how we can partner on confirmatory evidence studies to strengthen your regulatory submission.

This webinar explores relevant examples of how Data Science and Digital Health are accelerating pharmaceutical innovation and driving impact for patients. Bringing together global experts with diverse perspectives spanning regulatory, R&D and health tech, this conversation highlights innovative, RWD-driven approaches to drug development and regulatory decision-making. Najat, Noga, Jesper, and Evelyn discuss the need for different types of data to construct a complete clinical picture – and how a data-driven approach can drive impact across both research and clinical practice.

Our world had turned upside down, our ground had shifted below us, and we were trying to grasp at anything to hold on to.

We sat down with Evelyn Pyper, Senior Evidence Strategy Manager at PicnicHealth, to talk about successes, limitations, and areas for growth within the wearables industry.

PicnicHealth is launching a four-part webinar series that aims to reframe the “ROI” for RWE generation and tackle the question: beyond the return on investment for RWE, what is the risk of inaction?

2022 was the biggest and most exciting year yet for PicnicHealth - not only for our team, but for our Change Champions, PicnicHealth users, and research partners. We want to thank everyone for being a part of this incredible community and making this past year possible. Before we jump into 2023, join us as we look back at our favorite moments of last year. We raised $60 million in Series C funding! PicnicHealth is ecstatic to have raised a $60m Series C to help build deep, complete, and clinically-rich real-world datasets in several new diseases. The team spent the year growing our research program portfolio, connecting with new patient populations to initiate new studies; introducing new capabilities to our patient app to make it easier for patients to tell us more about their experiences by completing surveys, diaries, and more; and building new data features to help researchers gain new insights faster.

Mental health can mean a lot of different things to different people with seemingly vague definitions. MentalHealth.gov takes broad strokes to include emotional, psychological, and social well-being at the interface of how a person thinks, acts, and feels. Indicators that something is out of balance can present with a number of uncomfortable behaviors including having low or no energy, having unexplained aches or pains, or experiencing severe mood swings. It would be difficult to look through the entire list of possible symptoms and not relate at some level at some point in time, suggesting that mental wellness is just one fabric to the many layers that influence how we function on any given day. Unresolved or persistent mental health issues can lead to a diagnosis of mental illness, but it feels more fluid than other conditions or diseases that use more measurable diagnostic criteria such as abnormal lab values or imaging modalities to diagnose.

PicnicHealth’s research partners Roche-Genentech and other key opinion leaders in the hemophilia space presented data from PicnicHealth’s Hemophilia Cohort in an oral podium presentation and poster session at ASH 2022.

PicnicHealth Gives Back has returned for another year! Every time a patient contributes to a PicnicHealth research study, PicnicHealth will donate to a patient advocacy group until December 31, 2022.

Patient-centric real-world data and evidence are especially conducive to accelerating research of neurodegenerative diseases.

We are excited to announce the launch of our new Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) Research Cohort, a patient-centric real-world data source that provides comprehensive data to enable your therapy’s evidence goals.

PicnicHealth joined industry leaders as a Silver Sponsor of the MarketsandMarkets Real-world Evidence and Life Sciences Analytics Conference. View our featured presentation "Let's Get Direct: How working directly with patients optimizes delivery of complete RWD".

Webinar: PicnicHealth's patient-centered approach to real-world data collection

DIA RWE is focused on the broader scope and challenges of reframing clinical investigation using RWE. Here are a few of the key takeaways from a stimulating and engaging conference.

PicnicHealth, a patient-centered health technology company, and Bristol Myers Squibb are working together to leverage real-world evidence to study symptomatic obstructive hypertrophic cardiomyopathy patients within the DISCOVER-HCM Registry.

As life science continues to benefit from a growing number of real-world data sources, from EHRs and claims to PROs and devices, organizations must weigh two factors. One is whether an individual data source is structured to support their clinical and business needs. The other is why a patient-centric approach unlocks the true power of traditionally siloed data

Diversity and inclusivity in medical research are important, and yet, clinical trials tend to enroll a population skewed towards White. Real-world data can be part of the solution by removing barriers that limit representation across racial and ethnic groups.

We are excited to launch a new Lupus Nephritis real-world data research cohort that arms researchers with powerful data to support clinical research programs and drive evidence generation now and into the future.

With that, I’m very happy to share that PicnicHealth has raised a $60m Series C to build the deep, complete, and clinically-rich real-world data sets needed in 30 new diseases. As always, we’ll do this by partnering directly with patients to give them control over their own data.

Reading through my dad’s ALD-related medical records helped me paint a much clearer picture of what my family went through all those years ago.

PicnicHealth will present the “The Empowered Patient: Driving individual and population health with data & technology” at ISPOR 2022

It’s perhaps my greatest honor that while I lost Graham physically, I carry him every day to work with me.

Data completeness is essential to real-world data (RWD) quality. In this infographic, we will explore how data completeness is defined and improved.

2021 was another exciting year at PicnicHealth. We’re looking back and celebrating all that we accomplished with our patient volunteers and life science partners. Take a look with us. And thank you for coming along on our journey.

Because of what I’ve been through as a rare patient, I’m driven to help people facing similar challenges.

PicnicHealth is excited to announce our Holiday 2021 Donation Campaign. PicnicHealth is donating to patient advocacy groups everytime a patient joins a PicnicHealth research study until January 2, 2022.

We’re beginning a series: “Good Data Is”, where we’ll take a look at how to build good data and explore how best to optimize data capture, transformation and patient engagement

The American Society of Hematology (ASH) recently accepted two of our abstracts for the upcoming 63rd ASH Annual Meeting, which will be held December 11-14, 2021.

The Lupus Foundation of America estimates that 1.5 million Americans, and at least 5 million people worldwide, have a form of Lupus.

he Evidence Base and PicnicHealth partnered to put Data Completeness In Focus. Dan Drozd, MD, PicnicHealth’s Chief Medical Officer sat down with Darcy Hodge, Editor of the Evidence Base to talk about the importance of data completeness, unstructured data and additional factors that impact the generation of high-quality real-world evidence. Listen to the podcast, part of the In Focus feature by visiting The Evidence Base. A transcript of the interview appears below.

PicnicHealth is excited to partner with Komodo Health to enrich its patient-centered real-world data Research Platform. This collaboration will enable PicnicHealth to unlock rich new insights about complex diseases and treatment outcomes.

Sickle cell disease is the most common inherited blood disorder in the United States. The Centers for Disease Control and Prevention estimate that 100,000 people are living with sickle cell in the US

We’re excited to announce the formation of our Scientific Advisory Board (SAB) and welcome inaugural members, including Robert Kaplan, PhD, Jeffrey Brown, PhD, and Milena Gianfrancesco, PhD, MPH.

PicnicHealth is excited to partner with Komodo Health to enrich its patient-centered real-world data Research Platform. This collaboration will enable PicnicHealth to unlock rich new insights about complex diseases and treatment outcomes.

PicnicHealth partners with life science companies, academic research institutions, and health systems organizations in applying real world evidence for the advancement of patient care and treatment. We produce high quality multimodel datasets that cover a patient’s entire medical journey and are more comprehensive and customizable than existing sources of real-world data.

Recognizing the need for accelerating medical product development and modernizing the drug approval process, the 21st Century CURES Act was enacted in 2016 and augmented the ability for the FDA to incorporate real world data and patient perspectives into the drug approval process. While randomized clinical trials are still the gold standard, observational data is increasingly utilized to supplement clinical trial design, as synthetic controls in single arm trials and for label expansion.

PicnicHealth is excited to announce $35 million in funding, including a $25 million Series B led by Felicis Ventures, and a previously-unannounced $10 million Series A led by Amplify Partners, which also participated in the Series B.

Announcing the official launch of PicnicHealth's scientific research platform. PicnicHealth is gathering medical records data from proactively consenting patients, de-identifying it to ensure patient data privacy, and then aggregating it with the goal of deepening the scientific understanding of serious diseases. This data, known as “real-world data” helps researchers better understand what diseases look like outside of the controlled setting of clinical trials where research has traditionally been done.

PicnicHealth creates an easy-to-use, secure timeline of all of your medical records. Learn about what goes into the process of collecting your records and creating a timeline.